BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38656016)

  • 1. Evangely, the subcategorization has been announced in the 2023 Bethesda system for reporting thyroid cytopathology: let bygones be bygones in thyroidology!
    Sengul I; Sengul D
    Rev Assoc Med Bras (1992); 2024; 70(3):e20231511. PubMed ID: 38656016
    [No Abstract]   [Full Text] [Related]  

  • 2. The Bethesda thyroid terminology and progress towards international agreement on thyroid FNA cytology reporting.
    Cross PA; Poller D
    Cytopathology; 2010 Apr; 21(2):71-4. PubMed ID: 21054820
    [No Abstract]   [Full Text] [Related]  

  • 3. [The new system for reporting fine needle aspiration biopsies of the thyroid gland: Bethesda 2010].
    Dusková J
    Cesk Patol; 2011 Jan; 47(1):8-14. PubMed ID: 21416701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A brief description of the Bethesda System for reporting thyroid fine needle aspirates.
    Schinstine M
    Hawaii Med J; 2010 Jul; 69(7):176-8. PubMed ID: 20680928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Following the steps of Abu al-Qasim to Bethesda and beyond: the continuing deliberations in thyroid fine-needle aspiration.
    Baloch ZW; Bedrossian C
    Diagn Cytopathol; 2012 May; 40 Suppl 1():E1-3. PubMed ID: 22508684
    [No Abstract]   [Full Text] [Related]  

  • 6. The Bethesda System for Reporting Thyroid Cytopathology.
    Cibas ES; Ali SZ
    Thyroid; 2009 Nov; 19(11):1159-65. PubMed ID: 19888858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Bethesda System for Reporting Thyroid Cytopathology is applicable to frozen section diagnosis in children.
    Arnold MA; Nicol KK
    Pediatr Dev Pathol; 2015; 18(2):139-45. PubMed ID: 25625563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses.
    Rossi M; Lupo S; Rossi R; Franceschetti P; Trasforini G; Bruni S; Tagliati F; Buratto M; Lanza G; Damiani L; Degli Uberti E; Zatelli MC
    Endocrine; 2017 Jul; 57(1):98-107. PubMed ID: 27623969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Bethesda System for Reporting Thyroid Cytopathology II.
    Ali SZ; Cibas ES
    Acta Cytol; 2016; 60(5):397-398. PubMed ID: 27788511
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference.
    Baloch ZW; LiVolsi VA; Asa SL; Rosai J; Merino MJ; Randolph G; Vielh P; DeMay RM; Sidawy MK; Frable WJ
    Diagn Cytopathol; 2008 Jun; 36(6):425-37. PubMed ID: 18478609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On-site fine-needle aspiration cytology of thyroid nodules. Quality assurance of the Bethesda System for Reporting Thyroid Cytopathology (2008)].
    Bak M; Péter I; Nyári T; Simon P; Újlaky M; Boér A; Kásler M
    Orv Hetil; 2015 Oct; 156(41):1661-6. PubMed ID: 26551169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid FNA: challenges and opportunities.
    Cibas ES; Bibbo M
    Acta Cytol; 2011; 55(6):489-91. PubMed ID: 22156455
    [No Abstract]   [Full Text] [Related]  

  • 13. The Bethesda System for Reporting Thyroid Fine-Needle Aspiration Cytology: A Kuwaiti Experience - A Cytohistopathological Study of 374 Cases.
    Kapila K; Qadan L; Ali RH; Jaragh M; George SS; Haji BE
    Acta Cytol; 2015; 59(2):133-8. PubMed ID: 25676743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the bethesda system for reporting thyroid cytopathology and similar precursor thyroid cytopathology reporting schemes.
    Wong LQ; Baloch ZW
    Adv Anat Pathol; 2012 Sep; 19(5):313-9. PubMed ID: 22885380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid FNA terminology: The case for a single unified international system for thyroid FNA reporting.
    Poller DN; Cochand-Priollet B; Trimboli P
    Cytopathology; 2021 Nov; 32(6):714-717. PubMed ID: 34050989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in thyroid cytology reporting in the 3rd edition of the Bethesda system.
    J D
    Cesk Patol; 2024; 60(1):64-67. PubMed ID: 38697829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Bethesda terminology for reporting thyroid cytopathology: from theory to practice in Europe.
    Cochand-Priollet B; Schmitt FC; Tötsch M; Vielh P;
    Acta Cytol; 2011; 55(6):507-11. PubMed ID: 22156458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology.
    Jo VY; Stelow EB; Dustin SM; Hanley KZ
    Am J Clin Pathol; 2010 Sep; 134(3):450-6. PubMed ID: 20716802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2017 Bethesda System for Reporting Thyroid Cytopathology.
    Cibas ES; Ali SZ
    Thyroid; 2017 Nov; 27(11):1341-1346. PubMed ID: 29091573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid fine needle aspirate: a post-Bethesda update.
    Bose S; Walts AE
    Adv Anat Pathol; 2012 May; 19(3):160-9. PubMed ID: 22498581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.